Nitric oxide pilot trial demonstrates an 8.8% FEV1 increase after 2 weeks

Novoteris recently announced that the FDA has granted orphan drug designation for inhaled nitric oxide as a treatment for Cystic Fibrosis. The pilot trial demonstrated an 8.8% absolute improvement from baseline after 2 weeks. Phase 2 trials are planned for 2014. More info here: http://sixtyfiverosesblog.wordpress....oxide-therapy/
Source: Cystic Fibrosis CFTR Modulation and Gene Therapy Forum - Category: Respiratory Medicine Authors: Tags: CFTR Modulation and Gene Therapy Talk Source Type: forums